Just China raises $35M ahead of global trials

Biologics company Hangzhou Just Biotherapeutics Ltd. (Hangzhou, China) raised $35 million in a series B plus round led by Hillhouse Capital.

Read the full 211 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE